Al-Qahtani Ahmed A, Al-Anazi Mashael R, Al-Zoghaibi Fahad, Abdo Ayman A, Sanai Faisal M, Khan Mohammed Q, Albenmousa Ali, Al-Ashgar Hamad I, Al-Ahdal Mohammed N
Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi Arabia ; Department of Microbiology and Immunology, Alfaisal University School of Medicine, Riyadh, Saudi Arabia ; Liver Disease Research Center, King Saud University, Riyadh, Saudi Arabia.
Department of Infection and Immunity, Research Center, King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi Arabia.
Biomed Res Int. 2014;2014:357062. doi: 10.1155/2014/357062. Epub 2014 Aug 10.
Hepatitis C virus (HCV) is a single stranded RNA virus. It affects millions of people worldwide and is considered as a leading cause of liver diseases including cirrhosis and hepatocellular carcinoma. A recent study reported that TLR4 gene polymorphisms are good prognostic predictors and are associated with protection from liver fibrosis among Caucasians. This study aims to investigate the implication of genetic polymorphisms of TLR4 gene on the HCV infection in Saudi Arabian patients. Two SNPs in the TLR4 gene, rs4986790 (A/G) and rs4986791 (C/T), were genotyped in 450 HCV patients and 600 uninfected controls. The association analysis confirmed that both SNPs showed a significant difference in their distribution between HCV-infected patients and uninfected control subjects (P < 0.0001; OR = 0.404, 95% CI = 0.281-0.581) and (P < 0.0001; OR = 0.298, 95% CI = 0.201-0.443), respectively. More importantly, haplotype analysis revealed that four haplotypes, AC, GT, GC, and AT (rs4986790, rs4986791), were significantly associated with HCV infection when compared with control subjects. One haplotype AC was more prominently found when chronic HCV-infected patients were compared with cirrhosis/HCC patients (frequency = 94.7% and P = 0.04). Both TLR4 SNPs under investigation were found to be significantly implicated with HCV-infection among Saudi Arabian population.
丙型肝炎病毒(HCV)是一种单链RNA病毒。它影响着全球数百万人,被认为是包括肝硬化和肝细胞癌在内的肝脏疾病的主要病因。最近一项研究报告称,Toll样受体4(TLR4)基因多态性是良好的预后预测指标,与高加索人预防肝纤维化有关。本研究旨在调查TLR4基因多态性对沙特阿拉伯患者HCV感染的影响。对450例HCV患者和600例未感染对照者的TLR4基因中的两个单核苷酸多态性(SNP),即rs4986790(A/G)和rs4986791(C/T)进行基因分型。关联分析证实,这两个SNP在HCV感染患者和未感染对照者之间的分布均存在显著差异(P<0.0001;比值比[OR]=0.404,95%可信区间[CI]=0.281-0.581)和(P<0.0001;OR=0.298,95%CI=0.201-0.443)。更重要的是,单倍型分析显示,与对照者相比,四种单倍型AC、GT、GC和AT(rs4986790、rs4986791)与HCV感染显著相关。与肝硬化/肝细胞癌患者相比,慢性HCV感染患者中更显著地发现一种单倍型AC(频率=94.7%,P=0.04)。在沙特阿拉伯人群中,所研究的两个TLR4 SNP均与HCV感染显著相关。